Short Course Glucocorticoid Treatment for PTSD

Completed · Phase 4 · Has a placebo group

Conditions studied: Post-traumatic Stress Disorder

In brief

The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo

Key facts

Study ID

NCT00204737

Run by

University of Wisconsin, Madison

People needed

12

Starts

2004-12-01

Expected to finish

2009-01-01

Last updated by the study team

2020-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must meet Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for PTSD w/ symptom exacerbation (CAPS score ≥ 50)
• Stable on other psychotropic meds x1 month

You may not qualify if…

• Current or past history of bipolar, schizophrenic, or other psychotic disorder
• Organic mental disorder
• Alcohol or substance abuse in last 3 months
• Clinically significant hepatic or renal disease or other acute or unstable medical condition
• Chronic obstructive pulmonary disease (COPD), asthma, uncontrolled diabetes, rheumatologic diseases

Where it is running

• Catherine Johnson — Madison, Wisconsin, United States
• Wm. S. Middleton VA Hospital — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.